文献速递免疫规划传染病防控与疫情报告

血清型特异性侵袭能力、临床表现及侵袭性肺炎球菌疾病死亡率趋势的综合分析

A comprehensive analysis of serotype-specific invasive capacity, clinical presentations, and mortality trends of invasive pneumococcal disease.
PubMed 文献 · Vaccine · 2025-01-07

该研究基于马萨诸塞州<7岁儿童增强的侵袭性肺炎球菌疾病(IPD)监测和鼻咽部定植监测,估算血清型特异性侵袭能力(IC),即IPD年发病率除以携带率。共纳入293株IPD和1602株鼻咽部分离株,发现18C、38、7F、19A、3、22F和33F较11A、35B、6C和21有更高侵袭倾向,>24月龄儿童IC普遍较低,除14、6A等部分血清型外均主要表现为菌血症,35B、23B和11A致死比例最高。

要点

  • 18C、38、7F、19A、3、22F和33F较11A、35B、6C和21更易在定植后引起IPD。
  • 血清型特异性侵袭能力在>24月龄儿童中普遍低于<24月龄儿童。
  • 除14、6A、7F、11A、23A、20、35F、7C、6C和15F外,所有血清型主要表现为菌血症。

核心结论

  • 研究强调需要持续进行血清型特异性监测,以更好地了解新兴血清型的疾病潜力并指导最优疫苗接种策略。

研究设计与样本

  • 利用马萨诸塞州<7岁儿童增强的基于人群的IPD监测和相应呼吸道季节选定社区鼻咽部定植监测,估算肺炎链球菌血清型特异性侵袭能力。
  • 共纳入293株IPD分离株和1602株鼻咽部定植分离株。

主要发现

  • 最常见IPD血清型为19A(34.1%)、7F(9.2%)、15 BC(8.9%)、3(5.8%)和22F(4.8%)。
  • 18C、38、7F、19A、3、22F和33F较11A、35B、6C和21在鼻咽部定植后更易引起IPD。
  • 血清型特异性侵袭能力在>24月龄儿童中普遍低于<24月龄儿童。
  • 除14、6A、7F、11A、23A、20、35F、7C、6C和15F外,所有血清型主要表现为菌血症。
  • 肺炎归因于血清型14和20;35B、23B和11A导致的死亡百分比最高。

临床怎么用

  • 原文结论未据此给出具体临床推荐,仅强调持续血清型特异性监测以了解新兴血清型疾病潜力并指导最优疫苗接种策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pneumococcal conjugate vaccines (PCV) reduced invasive disease, but the overall prevalence of pneumococcal nasopharyngeal colonization among children has not changed significantly. Our knowledge of which serotypes, once colonized, hold a higher likelihood to cause invasive disease is limited. METHODS: Serotype-specific invasive capacity (IC) of Streptococcus pneumoniae was estimated using an enhanced population-based invasive pneumococcal disease (IPD) surveillance in children <7 years of age in Massachusetts and surveillance of nasopharyngeal (NP) colonization in selected Massachusetts communities in corresponding respiratory seasons. Serotype-specific IC was calculated by dividing the annual incidence of IPD by the carriage prevalence for each serotype. Serotype-specific relationship between NP carriage and IPD was evaluated by year, age group (<24 months vs 24-84 months), pre-PCV13 (2003/04, 2006/07, 2008/09) vs post-PCV13 (2010/11, 2013/14, 2015/2016) periods, clinical presentation, and outcome. RESULTS: A total of 293 IPD and 1602 NP isolates were included in the analysis. Most common IPD serotypes were 19A (34.1 %), 7F (9.2 %), 15 BC (8.9 %), 3 (5.8 %), and 22F (4.8 %). Serotypes 18C, 38, 7F, 19A, 3, 22F, and 33F displayed a higher propensity to cause IPD once colonizing the nasopharynx compared to 11A, 35B, 6C, and 21. Serotype-specific IC was generally lower in children older than 24 months. During the study period, we observed shifts in the dominant serotypes in relation to IC as well as changes between pre- to post-PCV13 era. Except for serotypes 14, 6A, 7F, 11A, 23A, 20, 35F, 7C, 6C and 15F all serotypes presented primarily as bacteremia. Pneumonia was attributed to serotypes 14 and 20; serotypes 35B, 23B, and 11A were responsible for the highest percentage of deaths. CONCLUSION: This study highlights the need for continued serotype-specific surveillance to better understand the disease potential of emerging serotypes and to guide optimal vaccination strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yildirim M, Keskinocak P, Hinderstein S, et al. A comprehensive analysis of serotype-specific invasive capacity, clinical presentations, and mortality trends of invasive pneumococcal disease. Vaccine. 2025. PMID: 39778476. doi:10.1016/j.vaccine.2024.126692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。